The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Open accessPublished version of a preprint
Abstract
The development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines and therapeutics will depend on understanding viral immunity. We studied T cell memory in 42 patients following recovery from COVID-19 (28 with mild disease and 14 with severe disease) and 16 unexposed donors, using interferon-γ-based assays with peptides spanning SARS-CoV-2 except ORF1. The breadth and magnitude of T cell responses were significantly higher in severe as compared with mild cases. Total and spike-specific T cell responses correlated with spike-specific antibody responses. We identified 41 peptides containing CD4+ and/or CD8+ epitopes, including six immunodominant regions. Six optimized CD8+ epitopes were defined, with peptide-MHC pentamer-positive cells displaying the central and effector memory phenotype. In mild cases, higher proportions of SARS-CoV-2-specific CD8+ T cells were observed. The identification of T cell responses associated with milder disease will support an understanding of protective immunity and highlights the potential of including non-spike proteins within future COVID-19 vaccine design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using HLA class I and II predicted peptide “megapools,” circulating SARS-CoV-2-specific CD8+ and CD4+ T cells were identified in COVID-19 acute, mild and convalescent patients [110, 118-125].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [120]
Experimental — accuracy not yet measuredIn the citing paper
“By contrast, VAERD has not usually occurred if a TH1 cell-biased CD4+ T cell response is elicited, reflected by increased levels of interferon-γ (IFNγ), IL-2 and tumour necrosis factor (TNF)44–46,49.”
From Immunological mechanisms of vaccine-induced protection against COVID-19 in humans (2021) · cites this paper as [46]
In the citing paper
“Robust CD4+ and CD8+ T cell memory is induced after COVID-19,22,39, 40, 41 and multiple COVID-19 vaccines elicit CD4+ and CD8+ T cell responses.26,42, 43, 44, 45”
From Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals (2021) · cites this paper as [40]
In the citing paper
“It should be noted that all plasma and sera tested completely inhibited entry at the lowest dilution tested and that T cell responses will contribute to control of SARS-CoV-2 infection, particularly in re-infected convalescent patients (Grifoni et al., 2020; Peng et al., 2020).”
From SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies (2021) · cites this paper as Peng et al., 2020
In the citing paper
“T cell responses are detected after almost all SARS-CoV-2 infections (Grifoni et al., 2020; Rydyznski Moderbacher et al., 2020; Peng et al., 2020; Sekine et al., 2020).”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Peng et al., 2020
In the citing paper
“In SARS-CoV-2 infections, the presence of virus-specific CD8+ T cells has been associated with better COVID-19 outcomes (Rydyznski Moderbacher et al., 2020; Peng et al., 2020).”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Peng et al., 2020
In the citing paper
“Current evidence suggests an early, robust, and diverse T cell response directed against SARS-CoV-2 correlates with milder COVID-19 outcomes126,131,132”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [132]
In the citing paper
“Severe COVID-19 has been associated with lower TCR diversity against SARS-CoV-2 epitopes131,132.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [132]
In the citing paper
“For CD8+ T cells, there are reports of diminished CD8+ cytotoxicity and cytokine production in severe cases126,132, while others report the opposite141, and still others find no differences142.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citationCryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0074-x · Cited by 2,838
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Cheng, L., Li, J., Wang, X., Wang, F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0901-9 · Cited by 2,614
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Diao, B., Wang, C., Tan, Y., Chen, X., Liu, Y., Ning, L., Chen, L., Li, M., Liu, Y., Wang, G., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00827 · Cited by 2,475
Self-citationFolegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., Bellamy, D., Bibi, S., Bittaye, M., Clutterbuck, E. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31604-4 · Cited by 2,419
Self-citation
Research works printed but not linked: 1
- Fehr, A. R. & Perlman, S. in Coronaviruses. Methods in Molecular Biology Vol. 1282 (eds Maier H., Bickerton E., Britton P.) 1–23 (Humana Press, 2015).
Cited by
Sorted by citations
Items 501–600 of 1,000
The characterization of CD8 + T-cell responses in COVID-19
Yang, Y., Miller, H. I., Byazrova, M. G., Cndotti, F., Benlagha, K., Câmara, N. O. S., Shi, J., Forsman, H. F., Lee, P. P. W., Yang, L., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2287118 · Cited by 21
Self-citationThe HLA-II immunopeptidome of SARS-CoV-2
Weingarten-Gabbay, S., Chen, D. W., Sarkizova, S., Taylor, H. B., Gentili, M., Hernandez, G. M., Pearlman, L. R., Bauer, M. R., Rice, C. M., Clauser, K. R., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113596 · Cited by 23
Sałkowska, A., Karwaciak, I., Karaś, K., Dastych, J., & Ratajewski, M. (2020) · Vaccines · doi:10.3390/vaccines8040673 · Cited by 21
SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals
Rha, M., Kim, A. R., & Shin, E. (2021) · Immune Network · doi:10.4110/in.2021.21.e2 · Cited by 20
Scaglione, A., Opp, S., Hurtado, A. M., Lin, Z., Pampeno, C., Noval, M. G., Thannickal, S. A., Stapleford, K. A., & Meruelo, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.719077 · Cited by 20
Neeland, M. R., Bannister, S., Clifford, V., Nguyen, J., Dohle, K., Overmars, I., Toh, Z. Q., Anderson, J., Donato, C. M., Sarkar, S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.741639 · Cited by 20
Understanding T cell aging to improve anti-viral immunity
Zhang, H., Weyand, C. M., Goronzy, J. J., & Gustafson, C. E. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.09.017 · Cited by 18
Peluso, M. J., Donatelli, J. L., & Henrich, T. J. (2021) · Translational research · doi:10.1016/j.trsl.2021.11.006 · Cited by 18
Qiu, X., Hua, X., Li, Q., Zhou, Q., & Chen, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.774776 · Cited by 19
Fouladseresht, H., Talepoor, A. G., Eskandari, N., Norouzian, M., Ghezelbash, B., Beyranvand, M. R., Nejadghaderi, S. A., Carson‐Chahhoud, K., Kolahi, A., & Safiri, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.785946 · Cited by 20
Vo, H. T. M., Maestri, A., Auerswald, H., Sorn, S., Lay, S., Seng, H., Sann, S., Ya, N., Pean, P., Dussart, P., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.817905 · Cited by 19
Beaton, B., Sasson, S. C., Rankin, K., Raedemaeker, J., Wong, A., Hastak, P., Phetsouphanh, C., Warden, A., Klemm, V., Munier, C. M. L., et al. (2022) · American Journal of Hematology · doi:10.1002/ajh.26619 · Cited by 19
The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update
Jasim, S. A., Mahdi, R. S., Bokov, D. O., Najm, M. A. A., Sobirova, G. N., Bafoeva, Z. O., Taifi, A., Alkadir, O. K. A., Mustafa, Y. F., Mirzaei, R., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28000 · Cited by 21
A robust deep learning workflow to predict CD8 + T-cell epitopes
Lee, C. H.-J., Huh, J., Buckley, P. R., Jang, M., Pinho, M. P., Fernandes, R. A., Antanaviciute, A., Simmons, A., & Koohy, H. (2023) · Genome Medicine · doi:10.1186/s13073-023-01225-z · Cited by 21
SARS-CoV-2 spike-specific TFH cells exhibit unique responses in infected and vaccinated individuals
He, R., Zheng, X., Zhang, J., Liu, B., Wang, Q., Wu, Q., Liu, Z., Chang, F., Hu, Y., Xie, T., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01650-x · Cited by 21
Yang, G., Cao, J., Qin, J., Mei, X., Deng, S., Xia, Y., Zhao, J., Wang, J., Luan, T., Chen, D., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01867-4 · Cited by 20
Self-citationInduction of SARS-CoV-2 Protein S-Specific CD8+ T Cells in the Lungs of gp96-Ig-S Vaccinated Mice
Fisher, E., Padula, L., Podack, K., O’Neill, K. E., Seavey, M. M., Jayaraman, P., Jasuja, R. R., & Štrbo, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.602254 · Cited by 18
Kostopoulos, I. V., Orologas‐Stavrou, N., Rousakis, P., Panteli, C., Ntanasis‐Stathopoulos, I., Charitaki, I., Korompoki, E., Gavriatopoulou, M., Kastritis, E., Trougakos, I. P., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9030546 · Cited by 18
Somogyi, E., Csiszovszki, Z., Molnár, L., Lőrincz, O., Tóth, J., Pattijn, S., Schockaert, J., Mazy, A., Miklós, I., Pántya, K., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.684152 · Cited by 18
Ma, T., Ryu, H., McGregor, M. M., Babcock, B. R., Neidleman, J. A., Xie, G., George, A. F., Frouard, J., Murray, V., Gill, G., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100465 · Cited by 19
Jing, L., Wu, X., Krist, M. P., Hsiang, T.-Y., Campbell, V. L., McClurkan, C. L., Favors, S. M., Hemingway, L. A., Godornes, C., Tong, D. Q., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.158126 · Cited by 18
Furuyama, W., Shifflett, K., Pinski, A. N., Griffin, A. J., Feldmann, F., Okumura, A., Gourdine, T., Jankeel, A., Lovaglio, J., Hanley, P. W., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.19.426885 · Cited by 19
Schmidt, K. G., Nganou‐Makamdop, K., Tenbusch, M., Kenz, B. E., Maier, C., Lapuente, D., Überla, K., Spriewald, B. M., Bergmann, S., Harrer, E. G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.627568 · Cited by 18
Individual HLA-A, -B, -C, and -DRB1 Genotypes Are No Major Factors Which Determine COVID-19 Severity
Schetelig, J., Heidenreich, F., Baldauf, H., Trost, S., Falk, B., Hoßbach, C., Real, R. G. L., Roers, A., Lindemann, D., Dalpke, A. H., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.698193 · Cited by 18
Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19
Wang, N., Vuerich, M., Kalbasi, A., Graham, J. J., Csizmadia, E., Manickas-Hill, Z., Woolley, A. E., David, C. N., Miller, E. M., Gorman, K. M., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103205 · Cited by 18
Using correlates to accelerate vaccinology
Openshaw, P. (2022) · Science · doi:10.1126/science.abn0007 · Cited by 17
Self-citationMeggiolaro, A., Schepisi, M. S., Nikolaidis, G., Mipatrini, D., Siddu, A., & Rezza, G. (2022) · Vaccines · doi:10.3390/vaccines10020157 · Cited by 19
Fahrner, J., Lahmar, I., Goubet, A., Haddad, Y., Carrier, A., Mazzenga, M., Drubay, D., Silva, C. A. C., Lyon COVID Study Group, de Sousa, E., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1441 · Cited by 20
Molecular Characteristics and Distribution of Adult Human Corneal Immune Cell Types
Li, Y., Jeong, J., & Song, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.798346 · Cited by 18
Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic
Alcendor, D. J., Matthews-Juarez, P., Smoot, D. T., Hildreth, J. E. K., Lamar, K. D., Tabatabai, M., Wilus, D. M., & Juárez, P. D. (2022) · Vaccines · doi:10.3390/vaccines10050755 · Cited by 18
Seidel, A., Zanoni, M., Groß, R. M., Krnavek, D., Erdemci-Evin, S., von Maltitz, P., Albers, D., Conzelmann, C., Liu, S., Weil, T., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.882918 · Cited by 17
Nucleic Acid Vaccines against SARS-CoV-2
Liu, Y., & Ye, Q. (2022) · Vaccines · doi:10.3390/vaccines10111849 · Cited by 17
Ishigaki, H., Yasui, F., Nakayama, M., Endo, A., Yamamoto, N., Yamaji, K., Nguyen, C. T., Kitagawa, Y., Sanada, T., Honda, T., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.967019 · Cited by 18
Fujii, S., Yamasaki, S., Iyoda, T., & Shimizu, K. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00239-1 · Cited by 18
Reeg, D. B., Hofmann, M., Neumann‐Haefelin, C., Thimme, R., & Luxenburger, H. (2023) · Pathogens · doi:10.3390/pathogens12020244 · Cited by 19
Shaw, R. H., Greenland, M., Stuart, A. S. V., Aley, P. K., Andrews, N. J., Cameron, J. C., Charlton, S., Clutterbuck, E., Collins, A. M., Darton, T. C., et al. (2023) · Journal of Infection · doi:10.1016/j.jinf.2023.03.027 · Cited by 18
Self-citationCOVID-19: from immune response to clinical intervention
Guo, Z.-Y., Tang, Y., Zhang, Z.-B., Liu, J., Zhuang, Y., & Li, T. (2024) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbae015 · Cited by 18
Yang, H. J., Hong, W., Shi, H., He, C., Hong, L., Zhou, Y., Yang, H., Alu, A., Chen, Z., Yang, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-55087-z · Cited by 18
Endothelial cell, myeloid, and adaptive immune responses in SARS‐CoV‐2 infection
Degauque, N., Haziot, A., Brouard, S., & Mooney, N. (2021) · The FASEB Journal · doi:10.1096/fj.202100024r · Cited by 14
A reasoned approach towards administering COVID‐19 vaccines to pregnant women
Pramanick, A., Kanneganti, A., Wong, J. L. J., Li, S. W., Dimri, P. S., Mahyuddin, A. P., Kumar, S., Illanes, S. E., Chan, J. K. Y., Su, L., et al. (2021) · Prenatal Diagnosis · doi:10.1002/pd.5985 · Cited by 19
Immunodominance complexity: lessons yet to be learned from dominant T cell responses to SARS-COV-2
Wellington, D., Yin, Z., Kessler, B. M., & Dong, T. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.08.009 · Cited by 18
Self-citationde Campos‐Mata, L., Vaquero, S. T., Tachó‐Piñot, R., Piñero, J., Grasset, E. K., Arrieta‐Aldea, I., Melero, N. R., Carolis, C., Horcajada, J. P., Cerutti, A., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1339 · Cited by 17
BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity
Vizcarra, P., Häemmerle, J., Velasco, H., Velasco, T., Fernández-Escribano, M., Vallejo, A., & Casado, J. L. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.10.074 · Cited by 18
Wang, Y., Duan, F., Zhu, Z., Yu, M., Jia, X., Dai, H., Wang, P., Qiu, X., Lu, Y., & Huang, J. (2021) · Cells · doi:10.3390/cells11010068 · Cited by 18
Redox Homeostasis and Immune Alterations in Coronavirus Disease-19
Bellanti, F., Buglio, A. L., & Vendemiale, G. (2022) · Biology · doi:10.3390/biology11020159 · Cited by 18
Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19
Legebeke, J., Lord, J., Penrice-Randal, R., Vallejo, A. F., Poole, S., Brendish, N. J., Dong, X., Hartley, C. S., Holloway, J. W., Lucas, J. S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.853265 · Cited by 18
Lee, K. S., Russ, B. P., Wong, T. Y., Horspool, A. M., Winters, M. T., Barbier, M., Bevere, J. R., Martínez, I., Damron, F. H., & Cyphert, H. A. (2022) · iScience · doi:10.1016/j.isci.2022.105038 · Cited by 18
Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2
Purbey, P. K., Roy, K., Gupta, S., & Paul, M. K. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2023.03.009 · Cited by 19
Crystal structure of the human LAG-3–HLA-DR1–peptide complex
Petersen, J., Llerena, C., Golzarroshan, B., Faoro, C., Triebel, F., & Rossjohn, J. (2024) · Science Immunology · doi:10.1126/sciimmunol.ads5122 · Cited by 17
Association of lymphocyte subsets with mortality in severe COVID‐19 pneumonia patients
Ashrafi, F., Nematollahi, P., Salmasi, M., Hedayat, A., & Amra, B. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24046 · Cited by 17
Ferreira, V. H., Marinelli, T. M., Ierullo, M., Ku, T., Hall, V. G., Majchrzak-Kita, B., Kulasingam, V., Humar, A., & Kumar, D. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab542 · Cited by 18
Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?
Tang, P. C. H., Ng, W. H., King, N. J. C., & Mahalingam, S. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010821 · Cited by 18
Clonal diversity predicts persistence of SARS-CoV-2 epitope-specific T-cell response
Zornikova, K. V., Khmelevskaya, A. A., Sheetikov, S. A., Kiryukhin, D. O., Shcherbakova, O. V., Titov, A., Zvyagin, I. V., & Efimov, G. A. (2022) · Communications Biology · doi:10.1038/s42003-022-04250-7 · Cited by 17
A systemic review of T-cell epitopes defined from the proteome of SARS-CoV-2
Jin, X., Liu, X. K., & Shen, C. (2022) · Virus Research · doi:10.1016/j.virusres.2022.199024 · Cited by 18
Multivariate indicators of disease severity in COVID-19
Bean, J., Kuri-Cervantes, L., Pennella, M., Betts, M. R., Meyer, N. J., & Hassan, W. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-31683-9 · Cited by 17
Complexity of immune responses in COVID-19
Mather, M. W., Jardine, L., Talks, B. J., Gardner, L. C. S., & Haniffa, M. A. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101545 · Cited by 19
Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-CoV-2
Gao, A., Chen, Z., Amitai, A., Doelger, J., Mallajosyula, V. V. A., Sundquist, E., Pereyra, F., Carrington, M. N., Davis, M. M., Streeck, H., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102311 · Cited by 33
Li, Z., Liu, J., Deng, H., Yang, X., Wang, H., Feng, X., Zelinskyy, G., Trilling, M., Sutter, K., Lu, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.15.383463 · Cited by 19
Self-citationSieling, P. A., King, T. B., Wong, R. M. H., Nguyen, A., Wnuk, K., Gabitzsch, E., Rice, A., Adisetiyo, H., Hermreck, M., Verma, M., et al. (2021) · medRxiv · doi:10.1101/2021.04.05.21254940 · Cited by 18
Jennewein, M. F., Schultz, M. D., Beaver, S., Battisti, P., Bakken, J., Hanson, D. J., Akther, J., Zhou, F., Mohamath, R., Singh, J., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.04.007 · Cited by 22
Barrios, Y., Franco, A., Sánchez‐Machín, I., Guedes, P. P., González‐Pérez, R., & Matheu, V. M. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108730 · Cited by 17
de Jesus, J. R., Galazzi, R. M., Júnior, C. A. L., & Arruda, M. A. Z. (2022) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2022.126964 · Cited by 16
Villemonteix, J., Cohen, L., Guihot, A., Guérin, V., Moulin, C., Caséris, M., Carol, A., Bonacorsi, S., & Carcelain, G. (2022) · Immunity Inflammation and Disease · doi:10.1002/iid3.617 · Cited by 15
Bekbossynova, M. S., Akhmaltdinova, L., Dossybayeva, K., Tauekelova, A., Smagulova, Z., Tsechoeva, T., Turebayeva, G., Sailybayeva, A., Kalila, Z., Mirashirova, T., et al. (2022) · Respiratory Research · doi:10.1186/s12931-022-02190-8 · Cited by 16
Viral infection and host immune response in diabetes
Joshi, G., Das, A., Verma, G., & Guchhait, P. (2023) · IUBMB Life · doi:10.1002/iub.2794 · Cited by 21
Delmonte, O. M., Oguz, C., Dobbs, K., Myint‐Hpu, K., Palterer, B., Abers, M. S., Draper, D., Truong, M., Kaplan, I. M., Gittelman, R., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.12.011 · Cited by 17
Self-citationRichards, K. A., Glover, M. A., Crawford, J. C., Thomas, P. G., White, C. L., & Sant, A. J. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab076 · Cited by 15
Mucosal immune responses in COVID19 - a living review
Pearson, C. F., Jeffery, R., Ahern, D., Almuttaqi, H., Alonzi, D. S., Alrubayyi, A., Alsaleh, G., Bart, V. M. T., Batchelor, V., Bayliss, R., et al. (2021) · Oxford Open Immunology · doi:10.1093/oxfimm/iqab002 · Cited by 16
Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection
Sui, Z., Dai, X., Lu, Q., Zhang, Y., Huang, M., Li, S., Peng, T., Xie, J., Zhang, Y., Wu, C., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00596-2 · Cited by 17
Self-citationLong Term Immune Response Produced by the SputnikV Vaccine
Martynova, E. V., Hamza, S., Garanina, E. E., Kabwe, E., Markelova, M., Shakirova, V. G., Хаертынова, И. М., Kaushal, N., Baranwal, M., Rizvanov, A. A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011211 · Cited by 18
Jearanaiwitayakul, T., Apichirapokey, S., Chawengkirttikul, R., Limthongkul, J., Seesen, M., Jakaew, P., Trisiriwanich, S., Sapsutthipas, S., Sunintaboon, P., & Ubol, S. (2021) · Viruses · doi:10.3390/v13112202 · Cited by 16
Casado, J. L., Vizcarra, P., Häemmerle, J., Velasco, H., Martín-Hondarza, A., Rodríguez-Domínguez, M., Velasco, T., Martín, S., Romero‐Hernández, B., Fernández-Escribano, M., et al. (2022) · Vaccine X · doi:10.1016/j.jvacx.2022.100165 · Cited by 16
An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2
Hassan, S. S., Kodakandla, V., Redwan, E. M. M. M., Lundstrom, K. H., Choudhury, P. P., El‐Aziz, T. M. A., Takayama, K., Kandimalla, R. J. L., Lal, A., Serrano‐Aroca, Á., et al. (2022) · PeerJ · doi:10.7717/peerj.13136 · Cited by 16
Ortega, M. M., da Silva, L. T., Candido, E. D., Zheng, Y., Tiyo, B. T., Ferreira, A. E. F., Correa‐Silva, S., Scagion, G. P., Leal, F. B., Chalup, V. N., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-14283-x · Cited by 17
Jeong, M., Kudchodkar, S. B., Gil, A., Jeon, B., Park, G. H., Cho, Y., Lee, H., Cheong, M. S., Kim, W., Hwang, Y.-H., et al. (2022) · Frontiers in Virology · doi:10.3389/fviro.2022.891540 · Cited by 15
Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination
Qi, F., Cao, Y., Zhang, S., & Zhang, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.964976 · Cited by 16
Pownall, W., Imhof, D., Trigo, N. F., Ganal-Vonarburg, S. C., Plattet, P., Monney, C., Forterre, F., Hemphill, A. F., & Oevermann, A. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.675219 · Cited by 15
Immune Responses against SARS-CoV-2—Questions and Experiences
Mangge, H., Kneihsl, M., Schnedl, W. J., Sendlhofer, G., Curcio, F., & Domenis, R. (2021) · Biomedicines · doi:10.3390/biomedicines9101342 · Cited by 16
Ancestral SARS-CoV-2-specific T cells cross-recognize Omicron
Gao, Y., Cai, C., Grifoni, A., Müller, T. R., Niessl, J., Olofsson, A., Humbert, M., Hansson, L., Österborg, A., Bergman, P., et al. (2022) · Nature Medicine · doi:10.1038/d41591-022-00017-z · Cited by 20
Rak, A. Y., Gorbunov, N., Kostevich, V. A., Av, S., Игоревна, П. П., Георгиевна, Р. Л., & Николаевна, И.-С. И. (2023) · Viruses · doi:10.3390/v15010230 · Cited by 15
State of the Art in Epitope Mapping and Opportunities in COVID-19
Hamed, S. M., Sakr, M. M., El-Housseiny, G. S., Wasfi, R., & Aboshanab, K. M. (2023) · Future Science OA · doi:10.2144/fsoa-2022-0048 · Cited by 16
Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19
Rümke, L. W., Smit, W. L., Bossink, A. W. J., Limonard, G. J. M., Muilwijk, D., Haas, L. E. M., Reusken, C. B. E. M., van der Wal, S., Thio, B. J., van Os, Y. M. G., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1046639 · Cited by 14
SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients
Onyango, T. B., Zhou, F., Bredholt, G., Brokstad, K. A., Lartey, S. L., Mohn, K. G.-I., Özgümüş, T., Kittang, B. R., Linchausen, D. W., Shafiani, S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1287388 · Cited by 14
Silent battles: immune responses in asymptomatic SARS-CoV-2 infection
Bert, N. L., & Samandari, T. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01127-z · Cited by 16
Sustained Vascular Inflammatory Effects of SARS-CoV-2 Spike Protein on Human Endothelial Cells
Gultom, M. L., Lin, L., Brandt, C. B., Milusev, A., Despont, A., Shaw, J., Döring, Y., Luo, Y., & Rieben, R. (2024) · Inflammation · doi:10.1007/s10753-024-02208-x · Cited by 19
Zhao, B., Zhong, M., Yang, Q., Hong, K., Xia, J., Li, X., Liu, Y., Chen, Y.-Q., Yang, J., Huang, C., et al. (2021) · Virologica Sinica · doi:10.1007/s12250-021-00348-0 · Cited by 15
Self-citationKlein, M. N., Wang, E. W., Zimand, P., Beauchamp, H., Donis, C., Ward, M. D., Martinez‐Hernandez, A., Tabatabai, A., Baddley, J. W., Bloch, E. M., et al. (2021) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-207356 · Cited by 15
Copley, H. C., Gragert, L. A., Leach, A. R., & Kosmoliaptsis, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669357 · Cited by 15
Blunck, B. N., Angelo, L. S., Henke, D. M., Avadhanula, V., Cusick, M. F., Ferlic‐Stark, L., Zechiedrich, L., Gilbert, B. E., & Piedra, P. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.823652 · Cited by 15
Where do T cell subsets stand in SARS-CoV-2 infection: an update
Tarique, M., Suhail, M., Naz, H., Muhammad, N., Tabrez, S. S. M., Zughaibi, T. A., Abuzenadah, A. M., Hashem, A. M., Shankar, H., Saini, C., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.964265 · Cited by 16
New insights into human immune memory from SARS‐CoV ‐2 infection and vaccination
Hartley, G. E., Edwards, E. S. J., O’Hehir, R. E., & van Zelm, M. C. (2022) · Allergy · doi:10.1111/all.15502 · Cited by 15
SARS-CoV-2 mutations affect antigen processing by the proteasome to alter CD8+ T cell responses
Wellington, D., Yin, Z., Yu, Z., Heilig, R., Davis, S. A., Fischer, R., Felce, S. L., Antoun, E., Hublitz, P., Beveridge, R. D. D., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20076 · Cited by 16
Self-citationGrandjean, L., Saso, A., Ortiz, A. T., Lam, T., Hatcher, J., Thistlethwayte, R., Harris, M., Best, T., Johnson, M., Wagstaffe, H. R., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3739808 · Cited by 15
Peng, H. T., Rhind, S. G., & Beckett, A. (2021) · JMIR Public Health and Surveillance · doi:10.2196/31554 · Cited by 16
Vaccine-induced CD8+ T cells are key to protection from SARS-CoV-2
Antoun, E., Peng, Y., & Dong, T. (2023) · Nature Immunology · doi:10.1038/s41590-023-01621-y · Cited by 14
Self-citationLiu, G., Antoun, E., Fries, A., Yao, X., Yin, Z., Dong, D., Wang, W., Wing, P. A. C., Dejnirattisa, W., Supasa, P., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63711-9 · Cited by 14
Self-citation6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort
Deisenhammer, F., Borena, W., Bauer, A., Kimpel, J., Rudzki, D., Schanda, K., Egeter, J., Hüfner, K., Sperner‐Unterweger, B., & Reindl, M. (2020) · Wiener klinische Wochenschrift · doi:10.1007/s00508-020-01795-7 · Cited by 13
Speeckaert, R., Lambert, J., Puig, L., Speeckaert, M. M., Lapeere, H., Schepper, S. D., & van Geel, N. (2021) · Drugs in R&D · doi:10.1007/s40268-021-00349-0 · Cited by 14
Virus-Induced CD8+ T-Cell Immunity and Its Exploitation to Contain the SARS-CoV-2 Pandemic
Federico, M. (2021) · Vaccines · doi:10.3390/vaccines9080922 · Cited by 13
Mendoza‐Ramírez, N. J., García‐Cordero, J., Shrivastava, G., & Cedillo‐Barrón, L. (2024) · Journal of Immunology Research · doi:10.1155/2024/9313267 · Cited by 15
Metadata
- Authors
- Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., Dejnirattisai, W., Rostron, T., Supasa, P., Liu, C., López-Camacho, C., Slon-Campos, J., Zhao, Y., Stuart, D. I., Paesen, G. C., Grimes, J. M., Antson, A. A., Bayfield, O. W., Hawkins, D. E. D. P., Ker, D.-S., Wang, B., Turtle, L., Subramaniam, K., Thomson, P., Zhang, P., Dold, C., Ratcliff, J., Simmonds, P., de Silva, T., Sopp, P., Wellington, D., Rajapaksa, U., Chen, Y.-L., Salio, M., Napolitani, G., Paes, W., Borrow, P., Kessler, B. M., Fry, J. W., Schwabe, N. F., Semple, M. G., Baillie, J. K., Moore, S. C., Openshaw, P. J. M., Ansari, M. A., Dunachie, S., Barnes, E., Frater, J., Kerr, G., Goulder, P., Lockett, T., Levin, R., Zhang, Y., Jing, R., Ho, L.-P., Oxford Immunology Network Covid-19 Response T cell Consortium, Barnes, E., Dong, D., Dong, T., Dunachie, S., Frater, J., Goulder, P., Kerr, G., Klenerman, P., Liu, G., McMichael, A., Napolitani, G., Ogg, G., Peng, Y., Salio, M., Yao, X., Yin, Z., ISARIC4C Investigators, Kenneth Baillie, J., Klenerman, P., Mentzer, A. J., Moore, S. C., Openshaw, P. J. M., Semple, M. G., Stuart, D. I., Turtle, L., Cornall, R. J., Conlon, C. P., Klenerman, P., Screaton, G. R., Mongkolsapaya, J., McMichael, A., Knight, J. C., Ogg, G., & Dong, T.
- Affiliations
- University of Oxford (GB)
- Centre for Human Genetics (GB)
- University of York (GB)
- University of Liverpool (GB)
- University of Sheffield (GB)
- ProImmune (United Kingdom) (GB)
- Oxford University Hospitals NHS Trust (GB)
- Worthing Hospital (GB)
- Capital Medical University (CN)
- University of Edinburgh (GB)
- Siriraj Hospital (TH)
- ORCID
- Dejnirattisai, Wanwisa
- Supasa, Piyada
- Liu, Chang
- López-Camacho, César
- Slon-Campos, Jose
- Zhao, Yuguang
- Paesen, Guido C.
- Grimes, Jonathan M.
- Antson, Alfred A.
- Bayfield, Oliver W.
- Hawkins, Dorothy E. D. P.
- Ker, De-Sheng
- Wang, Beibei
- Subramaniam, Krishanthi
- Thomson, Paul
- Zhang, Ping
- Dold, Christina
- Ratcliff, Jeremy
- Simmonds, Peter
- de Silva, Thushan
- Wellington, Dannielle
- Rajapaksa, Ushani
- Chen, Yi-Ling
- Paes, Wayne
- Borrow, Persephone
- Kessler, Benedikt M.
- Fry, Jeremy W.
- Ansari, M. Azim
- Zhang, Yonghong
- Ho, Ling-Pei
- Cornall, Richard J.
- Screaton, Gavin R.
- Mongkolsapaya, Juthathip
- Knight, Julian C.
- Venue
- Nature Immunology
- Published
- 2020-09-04
- Volume
- 21
- Issue
- 11
- Pages
- 1336-1345
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC7611020
- OpenAlex
- W3082438395
- Cited by
- 1,179
- References
- 42
- Citations by year
- 2026: 41 · 2025: 68 · 2024: 118 · 2023: 171 · 2022: 291 · 2021: 398 · 2020: 91
- FWCI
- 30.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Immunology (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Oxford University Research Archive (ORA) (University of Oxford) (acceptedVersion)
- PubMed Central (submittedVersion)
- Funders
- RCUK | Medical Research Council (MC_PC_19059)
- Chinese Academy of Medical Sciences (2018-I2M-2-002)
- China Scholarship Council
- Wellcome Trust (205228/Z/16/Z, 110058/Z/15/Z, 215091/Z/18/Z, 095541/A/11/Z, award 206377 to AAA)
- DH | NIHR | Health Services Research Programme (NIHR200907, CO-CIN-01)
- University of Liverpool
- University of Oxford
- University of Edinburgh
- DH | National Institute for Health Research (NIHR200927 /WHRG_P82523, NIHR201385 / WHRR P84026, NIHR200907)
- Imperial College London (IS-BRC-1215-20013)
- Worthing Hospital
- Oxford University Hospitals NHS Trust
- National Institutes of Health, National Key R&D Program of China
- University of York
- ProImmune Ltd
- Bill and Melinda Gates Foundation (MC_PC_19059)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- SARS-CoV-2, COVID-19 pandemic, T cell memory, CD4+ T cells, CD8+ T cells, epitope mapping, immunodominant epitopes, spike protein, disease severity, convalescent patients, central memory T cells, effector memory T cells, antiviral immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
